European AIDS Treatment Group (EATG)

Letter from EATG on the UN High-Level Meeting on TB political declaration

The European AIDS Treatment Group (EATG) calls on the EU governments to support South Africa and the G77 states and push back on the Trump administration’s attempts to remove access language from the declaration.

Read More →

Community response to the drug-resistant TB crisis in Europe

Video summary report from a series of meetings on drug-resistant TB held in May 2017.

Read More →

Webinars on TB diagnostics and TB treatment now online

The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) hosted two webinars this month on TB diagnostics and TB treatment, respectively.

Read More →

Webinar on TB treatment

The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) will host a webinar on TB treatment on 13 March 2017 at 15:00 – 16:30 CET.

Read More →

Webinar on TB diagnostics

The European AIDS Treatment Group (EATG) and Treatment Action Group (TAG) will host a webinar on TB diagnostics on 6 March 2017 at 15:00 – 16:30 CET.

Read More →

Webinar: Affordability and access to medicines

The European AIDS Treatment Group (EATG) will host a webinar on 22 April 2016, 13:00-14:00 CET to discuss current issues around intellectual property affecting universal access to medicines and sustainable health financing.

Read More →

Webinar: Current guidelines and treatment developments for HIV/TB co-infection

Join the European AIDS Treatment Group for a Webinar on Monday, Dec. 14, 4 to 5 PM. CET to discuss the current HIV/TB co-infection epidemic and treatment guidelines as well as the health products pipeline currently under development.

Read More →

Letter from community groups to regulators regarding bedaquiline phase III trial design

Several community groups express concerns regarding the STREAM stage II trial design for bedaquiline approval.

Read More →

Report: ECAB meeting on HIV/TB coinfection, May 17-19, 2013

The purpose of the report, based on the TB ECAB (European Community Advisory Board) meeting held in Brussels between May 17-19, 2013 is to inform ECAB and community advocates on HIV/TB treatment, care and research advocacy, in order to increase the capacity of the ECAB members and partners to get further involved in TB drugs, diagnostics development and access, and to identify key advocacy priorities.

Read More →

Page 1 of 1 · Total posts: 9

1